Blueshift Asset Management »

Apogee Therapeutics shares owned by Blueshift Asset Management

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Blueshift Asset Management from 13F filings

Historical chart of Blueshift Asset Management investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Blueshift Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Blueshift Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $236k 2.8k 84.17

More positions owned by Blueshift Asset Management

Ishares Tr Russell 2000 Etf (IWM)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Etsy (ETSY)
Avis Budget (CAR)
Match Group (MTCH)
O'reilly Automotive (ORLY)
Five Below (FIVE)
Murphy Usa (MUSA)
Equifax (EFX)
CarMax (KMX)
Nike CL B (NKE)
Walt Disney Company (DIS)
Affirm Hldgs Com Cl A (AFRM)
Target Corporation (TGT)
Royal Caribbean Cruises (RCL)

View all positions for Blueshift Asset Management

Top funds holding Apogee Therapeutics

FMR
VR Adviser
Wellington Management Company
BlackRock
Rtw Investments
Vanguard Capital Management
Henderson Group
State Street Corporation
Driehaus Capital Management
Perceptive Advisors
Paradigm Biocapital Advisors
Affinity Asset Advisors
Geode Capital Management
UBS Group
Vestal Point Capital

View all funds holding Apogee Therapeutics